can you drink while taking semaglutide and Alcohol: It Reduce Cravings? Semaglutide and Alcohol: What You

Novo Nordisk says the US FDA has approved a once daily pill version of Wegovy, described as the first approved pill of its kind The company said trials showed average weight loss of 16.6%, with about a third of roughly 1,300 participants losing 20% or more Novo Nordisk expects a US launch in early January 2026, with investors pushing shares up sharply after the announcement amid strong competition in the weight loss market US regulators have approved an oral version of Wegovy for chronic weight management, giving Novo Nordisk the first daily pill in this drug class cleared for obesity treatment, according to the company and US media reports

However, as polypeptide drugs, GLP-1RAs are easily hydrolyzed by enzymes in the gastrointestinal environment

Monitoring and adjustments matter

Body composition studies show lean mass decreases proportionally less than fat mass, with the ratio influenced by protein intake, resistance training, age, and baseline body composition

Current FDA-approved prescribing information for semaglutide does not require routine thyroid monitoring, including serum calcitonin measurements or thyroid ultrasound surveillance, in patients without risk factors

As additional endocrine and metabolic reagents enter the catalog, the company anticipates applying the same research-grade documentation paradigm to other compounds, allowing investigators to plan entire study portfolios using a consistent language of identity verification, stability characterization, and assay design